The role of m6A modification in physiology and disease
Chuan Yang,Yiyang Hu,Bo Zhou,Yulu Bao,Zhibin Li,Chunli Gong,Huan Yang,Sumin Wang,Yufeng Xiao
DOI: https://doi.org/10.1038/s41419-020-03143-z
2020-11-01
Cell Death and Disease
Abstract:Abstract Similar to DNA epigenetic modifications, multiple reversible chemical modifications on RNAs have been uncovered in a new layer of epigenetic modification. N6-methyladenosine (m 6 A), a modification that occurs in ~30% transcripts, is dynamically regulated by writer complex (methylase) and eraser (RNA demethylase) proteins, and is recognized by reader (m 6 A-binding) proteins. The effects of m 6 A modification are reflected in the functional modulation of mRNA splicing, export, localization, translation, and stability by regulating RNA structure and interactions between RNA and RNA-binding proteins. This modulation is involved in a variety of physiological behaviors, including neurodevelopment, immunoregulation, and cellular differentiation. The disruption of m 6 A modulations impairs gene expression and cellular function and ultimately leads to diseases such as cancer, psychiatric disorders, and metabolic disease. This review focuses on the mechanisms and functions of m 6 A modification in a variety of physiological behaviors and diseases.
cell biology